300804 广康生化
午间休市 10-14 11:30:00
资讯
新帖
简况
股市必读：广康生化（300804）10月12日董秘有最新回复
证券之星 · 10-13 01:26
股市必读：广康生化（300804）10月12日董秘有最新回复
广康生化：公司二硝体没有采用微通道工艺
证券之星 · 10-12 15:27
广康生化：公司二硝体没有采用微通道工艺
广康生化：K胺是公司试生产产品二硝体的下游产品
证券之星 · 10-12 15:15
广康生化：K胺是公司试生产产品二硝体的下游产品
广康生化（300804）10月8日主力资金净买入621.69万元
证券之星 · 10-09
广康生化（300804）10月8日主力资金净买入621.69万元
10月8日广康生化（300804）龙虎榜数据：机构净买入468.32万元
证券之星 · 10-08
10月8日广康生化（300804）龙虎榜数据：机构净买入468.32万元
公司问答丨广康生化：公司无生产6-硝体
格隆汇 · 10-08
公司问答丨广康生化：公司无生产6-硝体
广康生化(300804.SZ)：公司无生产6-硝体
中金财经 · 10-08
广康生化(300804.SZ)：公司无生产6-硝体
股市必读：广康生化新发布《关于全资子公司建设项目部分装置进入试生产阶段的公告》
证券之星 · 10-08
股市必读：广康生化新发布《关于全资子公司建设项目部分装置进入试生产阶段的公告》
广康生化（300804）9月29日主力资金净买入461.27万元
证券之星 · 09-30
广康生化（300804）9月29日主力资金净买入461.27万元
广康生化（300804）9月23日主力资金净卖出168.56万元
证券之星 · 09-24
广康生化（300804）9月23日主力资金净卖出168.56万元
广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份
智通财经 · 09-21
广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份
广康生化（300804）披露2026年半年度跟踪报告，9月14日股价上涨4.09%
证券之星 · 09-14
广康生化（300804）披露2026年半年度跟踪报告，9月14日股价上涨4.09%
广康生化（300804）披露将参加广东辖区投资者集体接待日暨半年报业绩说明会，9月08日股价上涨0.88%
证券之星 · 09-08
广康生化（300804）披露将参加广东辖区投资者集体接待日暨半年报业绩说明会，9月08日股价上涨0.88%
股市必读：广康生化新发布《关于特定股东减持股份计划期限届满暨实施情况的公告》
证券之星 · 09-07
股市必读：广康生化新发布《关于特定股东减持股份计划期限届满暨实施情况的公告》
9月3日广康生化发布公告，股东减持6万股
证券之星 · 09-03
9月3日广康生化发布公告，股东减持6万股
股市必读：广康生化新发布《2026年半年度报告摘要》
证券之星 · 08-31
股市必读：广康生化新发布《2026年半年度报告摘要》
广康生化（300804）2026年中报简析：净利润同比下降88.6%，三费占比上升明显
证券之星 · 08-29
广康生化（300804）2026年中报简析：净利润同比下降88.6%，三费占比上升明显
广康生化(300804.SZ)：上半年净利润330.67万元 同比下降88.6%
中金财经 · 08-27
广康生化(300804.SZ)：上半年净利润330.67万元 同比下降88.6%
图解广康生化中报：第二季度单季净利润同比下降67.39%
证券之星 · 08-27
图解广康生化中报：第二季度单季净利润同比下降67.39%
广康生化(300804)6月30日股东户数0.63万户，较上期减少16.84%
证券之星 · 08-27
广康生化(300804)6月30日股东户数0.63万户，较上期减少16.84%
加载更多
公司概况
公司名称：
广东广康生化科技股份有限公司
所属行业：
化学原料和化学制品制造业
上市日期：
2023-06-27
主营业务：
广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是联苯肼酯、甲氧虫酰肼等杀虫剂；克菌丹、灭菌丹、噻呋酰胺、土菌灵、萎锈灵等杀菌剂；甜菜宁、甜菜安、乙氧呋草黄等除草剂。公司是国家高新技术企业、国家农药定点生产企业、广东省专精特新中小企业。
发行价格：
42.45
{"stockData":{"symbol":"300804","market":"SZ","secType":"STK","nameCN":"广康生化","latestPrice":44.64,"timestamp":1791950559000,"preClose":45.14,"halted":0,"volume":998152,"delay":0,"changeRate":-0.0111,"floatShares":27500000,"shares":74000000,"eps":0.2028,"marketStatus":"午间休市","change":-0.5,"latestTime":"10-14 11:30:00","open":44.9,"high":46.09,"low":44.36,"amount":44976400,"amplitude":0.0383,"askPrice":44.65,"askSize":2,"bidPrice":44.64,"bidSize":12,"shortable":0,"etf":0,"ttmEps":0.2028,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791954000000},"marketStatusCode":3,"adr":0,"adjPreClose":45.14,"symbolType":"stock","openAndCloseTimeList":[[1791941400000,1791948600000],[1791954000000,1791961200000]],"highLimit":49.65,"lowLimit":40.63,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":74000000,"isCdr":false,"pbRate":2.46,"roa":"--","peRate":220.118343,"roe":"0.24%","epsLYR":0.55,"committee":0.292683,"marketValue":3303000000,"turnoverRate":0.0363,"status":1,"floatMarketCap":1228000000},"requestUrl":"/m/hq/s/300804","defaultTab":"news","newsList":[{"id":"2675804853","title":"股市必读：广康生化（300804）10月12日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2675804853","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2675804853?lang=zh_cn&edition=full","pubTime":"2026-10-13 01:26","pubTimestamp":1791825972,"startTime":"0","endTime":"0","summary":"截至2026年10月12日收盘，广康生化报收于45.02元，下跌2.26%，换手率9.97%，成交量2.74万手，成交额1.23亿元。董秘最新回复投资者： 2026 年初K胺的价格为 12.55 万元/吨，9 月已升至约 20.75 万元/吨，呈现上涨态势 。K胺是公司试生产产品二硝体的下游产品，公司截至目前尚未申请K胺的安全设计专篇，不涉及K胺的生产和销售，K胺市场价格波动对公司经营业绩无重大影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101300001695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674822445","title":"广康生化：公司二硝体没有采用微通道工艺","url":"https://stock-news.laohu8.com/highlight/detail?id=2674822445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674822445?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:27","pubTimestamp":1791790027,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)10月12日在投资者关系平台上答复投资者关心的问题。投资者提问：湖北晟康 2﹣硝基3﹣甲基苯甲酸硝化工段反应器类型，是否微通道连续流？广康生化回复：尊敬的投资者，您好！公司二硝体没有采用微通道工艺。谢谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200014664.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674375822","title":"广康生化：K胺是公司试生产产品二硝体的下游产品","url":"https://stock-news.laohu8.com/highlight/detail?id=2674375822","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674375822?lang=zh_cn&edition=full","pubTime":"2026-10-12 15:15","pubTimestamp":1791789318,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化(300804)10月12日在投资者关系平台上答复投资者关心的问题。投资者提问：2026 年初K胺的价格为 12.55 万元/吨，9 月已升至约 20.75 万元/吨，呈现上涨态势 。K胺价格上升对公司业绩是否有重大影响呢？请问贵公司今年生产和销售多少K胺呢？广康生化回复：尊敬的投资者，您好！K胺是公司试生产产品二硝体的下游产品，公司截至目前尚未申请K胺的安全设计专篇，不涉及K胺的生产和销售，K胺市场价格波动对公司经营业绩无重大影响。谢谢您的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200014393.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674172881","title":"广康生化（300804）10月8日主力资金净买入621.69万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674172881","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674172881?lang=zh_cn&edition=full","pubTime":"2026-10-09 09:10","pubTimestamp":1791508230,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年10月8日收盘，广康生化报收于46.62元，下跌15.86%，换手率18.6%，成交量5.11万手，成交额2.5亿元。10月8日的资金流向数据方面，主力资金净流入621.69万元，占总成交额2.49%，游资资金净流入2582.29万元，占总成交额10.34%，散户资金净流出3203.98万元，占总成交额12.84%。融券方面，融券卖出300.0股，融券偿还500.0股，融券余量7700.0股，融券余额35.9万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100900007117.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673073835","title":"10月8日广康生化（300804）龙虎榜数据：机构净买入468.32万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673073835","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673073835?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:43","pubTimestamp":1791452592,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年10月8日公布的交易公开信息显示，广康生化因日跌幅达到15%的前5只证券登上龙虎榜。此次是近5个交易日内第1次上榜。截至2026年10月8日收盘，广康生化报收于46.62元，下跌15.86%，换手率18.6%，成交量5.11万手，成交额2.5亿元。从龙虎榜公布的当日买卖数据来看，机构合计净买入468.32万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800023229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673020357","title":"公司问答丨广康生化：公司无生产6-硝体","url":"https://stock-news.laohu8.com/highlight/detail?id=2673020357","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673020357?lang=zh_cn&edition=full","pubTime":"2026-10-08 17:02","pubTimestamp":1791450141,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673024513","title":"广康生化(300804.SZ)：公司无生产6-硝体","url":"https://stock-news.laohu8.com/highlight/detail?id=2673024513","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673024513?lang=zh_cn&edition=full","pubTime":"2026-10-08 15:47","pubTimestamp":1791445621,"startTime":"0","endTime":"0","summary":"格隆汇10月8日丨广康生化(300804.SZ)在投资者互动平台表示，公司无生产6-硝体。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20261008/32390067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673654014","title":"股市必读：广康生化新发布《关于全资子公司建设项目部分装置进入试生产阶段的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2673654014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673654014?lang=zh_cn&edition=full","pubTime":"2026-10-08 00:58","pubTimestamp":1791392289,"startTime":"0","endTime":"0","summary":"截至2026年9月30日收盘，广康生化报收于55.41元，上涨12.48%，换手率21.15%，成交量5.82万手，成交额3.11亿元。当日关注点交易信息汇总：9月30日主力资金净流入2099.47万元，占总成交额6.75%。公司公告汇总：全资子公司湖北晟康化工获准开展2-硝基-3-甲基苯甲酸等装置试生产，期限为2026年10月9日至2027年10月8日。该产品是合成高效杀虫剂氯虫苯甲酰胺的重要中间体。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800000679.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671226953","title":"广康生化（300804）9月29日主力资金净买入461.27万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2671226953","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671226953?lang=zh_cn&edition=full","pubTime":"2026-09-30 09:01","pubTimestamp":1790730118,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月29日收盘，广康生化报收于49.26元，上涨11.07%，换手率10.05%，成交量2.76万手，成交额1.33亿元。9月29日的资金流向数据方面，主力资金净流入461.27万元，占总成交额3.46%，游资资金净流入17.55万元，占总成交额0.13%，散户资金净流出478.82万元，占总成交额3.59%。近5日资金流向一览见下表：广康生化融资融券信息显示，融资方面，当日融资买入2472.74万元，融资偿还897.03万元，融资净买入1575.71万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000007429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669743054","title":"广康生化（300804）9月23日主力资金净卖出168.56万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669743054","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669743054?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:05","pubTimestamp":1790211934,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，广康生化报收于46.76元，上涨4.35%，换手率5.31%，成交量1.46万手，成交额6766.66万元。9月23日的资金流向数据方面，主力资金净流出168.56万元，占总成交额2.49%，游资资金净流出235.88万元，占总成交额3.49%，散户资金净流入404.44万元，占总成交额5.98%。融券方面，融券卖出2200.0股，融券偿还800.0股，融券余量5000.0股，融券余额23.38万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400008876.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669236168","title":"广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2669236168","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669236168?lang=zh_cn&edition=full","pubTime":"2026-09-21 19:40","pubTimestamp":1789990811,"startTime":"0","endTime":"0","summary":"智通财经APP讯，广康生化(300804.SZ)发布公告，持有公司股份39万股(占公司总股本0.527%)的特定股东共青城华拓至盈贰号投资合伙企业(有限合伙)(简称“华拓至盈贰号”)计划在公告披露之日起三个交易日后的三个月内以集中竞价交易或大宗交易减持公司股份39万股(占公司总股本比例0.527%)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1498921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"广康生化(300804.SZ)：华拓至盈贰号拟减持39万股公司股份","news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667953652","title":"广康生化（300804）披露2026年半年度跟踪报告，9月14日股价上涨4.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667953652","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667953652?lang=zh_cn&edition=full","pubTime":"2026-09-14 17:44","pubTimestamp":1789379080,"startTime":"0","endTime":"0","summary":"截至2026年9月14日收盘，广康生化报收于42.29元，较前一交易日上涨4.09%，最新总市值为31.29亿元。近日，华泰联合证券有限责任公司发布《关于广东广康生化科技股份有限公司2026年半年度跟踪报告》。保荐人每月查看募集资金专户，列席股东会和董事会各一次，发表专项意见5次。公司归母净利润同比下降88.60%，主要受产能利用率低、原材料价格上涨及客户采购模式变化影响，保荐人已提请公司关注风险并采取应对措施。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091400023821.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665211053","title":"广康生化（300804）披露将参加广东辖区投资者集体接待日暨半年报业绩说明会，9月08日股价上涨0.88%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665211053","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665211053?lang=zh_cn&edition=full","pubTime":"2026-09-08 18:05","pubTimestamp":1788861957,"startTime":"0","endTime":"0","summary":"截至2026年9月8日收盘，广康生化报收于45.65元，较前一交易日上涨0.88%，最新总市值为33.78亿元。该股当日开盘45.25元，最高46.48元，最低44.8元，成交额达3970.01万元，换手率为3.16%。广康生化于近日披露《关于参加2026年广东辖区投资者集体接待日暨辖区上市公司半年报业绩说明会活动的公告》。公司董事长兼总经理蔡丹群、董事会秘书兼财务总监陈海霞将就公司2026年半年度业绩、公司治理、发展战略及经营状况等与投资者进行在线交流。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090800028750.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665362043","title":"股市必读：广康生化新发布《关于特定股东减持股份计划期限届满暨实施情况的公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2665362043","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665362043?lang=zh_cn&edition=full","pubTime":"2026-09-07 01:27","pubTimestamp":1788715628,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，广康生化报收于45.08元，下跌1.68%，换手率3.28%，成交量9007.0手，成交额4121.91万元。当日关注点交易信息汇总：9月4日主力资金净流出146.2万元，占总成交额3.55%。公司公告汇总关于特定股东减持股份计划期限届满暨实施情况的公告广东广康生化科技股份有限公司特定股东减持计划已届满：华拓至远叁号减持60,000股，占总股本0.0811%，减持均价39.73元/股；华拓至盈贰号未减持。本次减持未导致公司控制权变更，不影响公司治理结构及持续经营。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090700000732.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664879819","title":"9月3日广康生化发布公告，股东减持6万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2664879819","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664879819?lang=zh_cn&edition=full","pubTime":"2026-09-03 19:01","pubTimestamp":1788433284,"startTime":"0","endTime":"0","summary":"证券之星消息，9月3日广康生化发布公告《广康生化:关于特定股东减持股份计划期限届满暨实施情况的公告》，其股东深圳市华拓至远叁号投资企业(有限合伙)于2026年7月30日合计减持6.0万股，占公司目前总股本的0.0811%，变动期间该股股价上涨8.29%，截止7月30日收盘报39.97元。股东增减持详情见下表：根据广康生化2026年中报公布的十大股东详情如下：本文数据来源于广康生化公告，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300036074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663902866","title":"股市必读：广康生化新发布《2026年半年度报告摘要》","url":"https://stock-news.laohu8.com/highlight/detail?id=2663902866","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663902866?lang=zh_cn&edition=full","pubTime":"2026-08-31 07:58","pubTimestamp":1788134292,"startTime":"0","endTime":"0","summary":"公司公告汇总：2026年半年度报告显示净利润同比下降88.60%，经营活动现金流量净额为-7345.00万元，同比减少289.92%。公司公告汇总：公司拟继续开展总额度不超过5,000万美元的外汇衍生品交易业务，授权期自2026年9月23日起12个月内有效。公司公告汇总：截至2026年6月30日，募集资金余额为250,684,256.86元；报告期内投入10,632.30万元，累计投入35,040.79万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083100002006.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0229","300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663016248","title":"广康生化（300804）2026年中报简析：净利润同比下降88.6%，三费占比上升明显","url":"https://stock-news.laohu8.com/highlight/detail?id=2663016248","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663016248?lang=zh_cn&edition=full","pubTime":"2026-08-29 06:48","pubTimestamp":1787957338,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期广康生化发布2026年中报。截至本报告期末，公司营业总收入3.82亿元，同比下降4.19%，归母净利润330.67万元，同比下降88.6%。本报告期广康生化三费占比上升明显，财务费用、销售费用和管理费用总和占总营收同比增幅达31.27%。去年的净利率为5.35%，算上全部成本后，公司产品或服务的附加值一般。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082900013058.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662086198","title":"广康生化(300804.SZ)：上半年净利润330.67万元 同比下降88.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662086198","media":"中金财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662086198?lang=zh_cn&edition=full","pubTime":"2026-08-27 22:37","pubTimestamp":1787841422,"startTime":"0","endTime":"0","summary":"格隆汇8月27日丨广康生化(300804.SZ)公布半年度报告，报告期内，公司实现营业收入38,221.11万元，较上年同期下降4.19%；实现归属于上市公司股东的净利润330.67万元，较上年同期下降88.60%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260827/32350735.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662709741","title":"图解广康生化中报：第二季度单季净利润同比下降67.39%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662709741","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662709741?lang=zh_cn&edition=full","pubTime":"2026-08-27 19:02","pubTimestamp":1787828565,"startTime":"0","endTime":"0","summary":"证券之星消息，广康生化2026年中报显示，上半年度公司主营收入3.82亿元，同比下降4.19%；归母净利润330.67万元，同比下降88.6%；扣非净利润280.42万元，同比下降89.8%；其中2026年第二季度，公司单季度主营收入2.22亿元，同比上升4.77%；单季度归母净利润388.22万元，同比下降67.39%；单季度扣非净利润417.91万元，同比下降66.99%；负债率38.61%，投资收益165.7万元，财务费用1108.24万元，毛利率21.03%。财报数据概要请见下图:本文数据来源于广康生化2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700045198.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662703261","title":"广康生化(300804)6月30日股东户数0.63万户，较上期减少16.84%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662703261","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662703261?lang=zh_cn&edition=full","pubTime":"2026-08-27 18:15","pubTimestamp":1787825750,"startTime":"0","endTime":"0","summary":"证券之星消息，近日广康生化披露，截至2026年6月30日公司股东户数为6263.0户，较3月31日减少1268.0户，减幅为16.84%。在农化制品行业个股中，广康生化股东户数低于行业平均水平，截至6月30日，农化制品行业平均股东户数为4.91万户。从股价来看，2026年3月31日至2026年6月30日，广康生化区间跌幅为31.45%，在此期间股东户数减少1268.0户，减幅为16.84%。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082700043792.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300804","BK0229"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791950589418,"stockEarnings":[{"period":"1week","weight":-0.1853},{"period":"1month","weight":0.111},{"period":"3month","weight":0.2612},{"period":"6month","weight":-0.1125},{"period":"1year","weight":0.1396},{"period":"ytd","weight":0.2953}],"compareEarnings":[{"period":"1week","weight":-0.0108},{"period":"1month","weight":-0.0224},{"period":"3month","weight":-0.0391},{"period":"6month","weight":-0.0628},{"period":"1year","weight":-0.0228},{"period":"ytd","weight":-0.0423}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东广康生化科技股份有限公司","boardCode":"AI0026","boardName":"化学原料和化学制品制造业","stockholders":"6263人(较上一季度减少16.84%)","perCapita":"4390股","listingDate":"2023-06-27","address":"广东省清远市英德市农用化工产业链专用基地(英德市沙口镇红丰管理区)","registeredCapital":"7400万元","survey":" 广东广康生化科技股份有限公司的主营业务是农药原药、中间体、制剂的研发、生产和销售。公司的主要产品是联苯肼酯、甲氧虫酰肼等杀虫剂；克菌丹、灭菌丹、噻呋酰胺、土菌灵、萎锈灵等杀菌剂；甜菜宁、甜菜安、乙氧呋草黄等除草剂。公司是国家高新技术企业、国家农药定点生产企业、广东省专精特新中小企业。","listedPrice":42.45},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"广康生化,300804,广康生化股票,广康生化股票老虎,广康生化股票老虎国际,广康生化行情,广康生化股票行情,广康生化股价,广康生化股市,广康生化股票价格,广康生化股票交易,广康生化股票购买,广康生化股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"广康生化(300804)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供广康生化(300804)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}